Paul F Kramer

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2022
Publications (10 Years): 2

Top Topics

Prefrontal Cortex

Parkinson Disease

Top Venues

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Science (New York, N.Y.)

National Institute of Neurological Disorders and Stroke

Oregon Health and Science University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institute of Neurological Disorders and Stroke Jan 10 2017

United States

Post-doctoral Fellow

National Institutes of Health

United States

Postbac Fellow :: NIAAA

Education History

Oregon Health and Science University - Dec 16 2016

United States

PHD :: Vollum Institute

Publications

Changliang Liu, Xintong Cai, Andreas Ritzau-Jost, Paul F Kramer, Yu-Long Li, Zayd M Khaliq, Stefan Hallermann, Pascal S Kaeser
An action potential initiation mechanism in distal axons for the control of dopamine release. Science (New York, N.Y.) 375 (6587) (2022)
Paul F Kramer, Emily L Twedell, Jung Hoon Shin, Renshu Zhang, Zayd M Khaliq
Axonal mechanisms mediating γ-aminobutyric acid receptor type A (GABA-A) inhibition of striatal dopamine release. eLife 9 (2020)
Paul F Kramer, John T Williams
Cocaine Decreases Metabotropic Glutamate Receptor mGluR1 Currents in Dopamine Neurons by Activating mGluR5. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 40 (10) (2015)